Innoviva
INVA
#5095
Rank
HK$12.25 B
Marketcap
HK$163.92
Share price
1.59%
Change (1 day)
9.91%
Change (1 year)

Earnings for Innoviva (INVA)

Earnings in 2025 (TTM): HK$1.22 Billion

According to Innoviva's latest financial reports the company's current earnings are HK$0.38 Billion. In 2024 the company made an earning of HK$0.29 Billion a decrease over its 2023 earnings that were of HK$1.51 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Innoviva from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) HK$1.22 B320.34%
2024 HK$0.29 B-80.74%
2023 HK$1.51 B-32.36%
2022 HK$2.23 B-35.56%
2021 HK$3.46 B25.7%
2020 HK$2.75 B52.11%
2019 HK$1.81 B10.77%
2018 HK$1.63 B56.59%
2017 HK$1.04 B125.53%
2016 HK$0.46 B-417.36%
2015 -HK$0.15 Billion-74.49%
2014 -HK$0.58 Billion-25.19%
2013 -HK$0.77 Billion430.06%
2012 -HK$0.15 Billion-83.92%
2011 -HK$0.9 Billion39.82%
2010 -HK$0.65 Billion2.84%
2009 -HK$0.63 Billion-8.62%
2008 -HK$0.69 Billion-47.92%
2007 -HK$1.32 Billion-5.92%
2006 -HK$1.4 Billion19.8%
2005 -HK$1.17 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Onconova Therapeutics
ONTX
-HK$0.15 Billion-111.60%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
-HK$1.25 Billion-201.89%๐Ÿ‡บ๐Ÿ‡ธ USA